These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35209071)

  • 1. Inhibitory Effect of Ursolic Acid on the Migration and Invasion of Doxorubicin-Resistant Breast Cancer.
    Zong L; Cheng G; Zhao J; Zhuang X; Zheng Z; Liu Z; Song F
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment.
    Tang Q; Liu Y; Li T; Yang X; Zheng G; Chen H; Jia L; Shao J
    Oncotarget; 2016 Nov; 7(45):73114-73129. PubMed ID: 27683033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction.
    Luo F; Zhao J; Liu S; Xue Y; Tang D; Yang J; Mei Y; Li G; Xie Y
    Biochem Pharmacol; 2022 Nov; 205():115278. PubMed ID: 36191625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro.
    Shan JZ; Xuan YY; Ruan SQ; Sun M
    Chin J Integr Med; 2011 Aug; 17(8):607-11. PubMed ID: 21826595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT; Wu CH; Yen GC
    Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark.
    Mishra T; Arya RK; Meena S; Joshi P; Pal M; Meena B; Upreti DK; Rana TS; Datta D
    PLoS One; 2016; 11(7):e0159430. PubMed ID: 27453990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
    Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
    Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines.
    Huang CY; Lin CY; Tsai CW; Yin MC
    Toxicol In Vitro; 2011 Oct; 25(7):1274-80. PubMed ID: 21539908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effects.
    Ji X; Tang Q; Pang P; Wu J; Kirk TB; Xu J; Ma D; Xue W
    Colloids Surf B Biointerfaces; 2018 Oct; 170():293-302. PubMed ID: 29936382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
    Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
    Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.
    Zhu Q; Jin L; Casero RA; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2012 Nov; 136(1):57-66. PubMed ID: 22976807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
    Chen JM; Bai JY; Yang KX
    IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.
    Manni A; Wechter R; Gilmour S; Verderame MF; Mauger D; Demers LM
    Int J Cancer; 1997 Jan; 70(2):175-82. PubMed ID: 9009157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
    Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus.
    Li W; Luo L; Shi W; Yin Y; Gao S
    Environ Toxicol; 2021 Feb; 36(2):267-275. PubMed ID: 33009882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.